Sionna Therapeutics Inc.
SION | NASDAQ
$6
+$0.04 (+0.67%)
At close: Sep 21, 2026, 4:00 PM ET
$5.94
-$0.06 (-0.92%)
Pre-market:
Sep 22, 2026, 8:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | -75.27M | -61.69M | -47.26M | -40.24M |
Depreciation & Amortization | -3.05M | 668K | 583K | 122K |
Stock-Based Compensation | 12.07M | 3.71M | 2.26M | 1.69M |
Other Working Capital | -2.24M | -3.54M | -945K | 4.28M |
Other Non-Cash Items | 2.61M | 7.6M | 1.51M | -400K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.65M | -3.08M | -783K | 2.76M |
Operating Cash Flow | -66.3M | -52.79M | -43.7M | -36.07M |
Capital Expenditures | -377K | -27K | -1.12M | -1.87M |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -325.03M | -182.84M | -23.53M | -40.39M |
Sales Maturities Of Investments | 206.65M | 55.96M | 52M | 13M |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -118.75M | -126.91M | 27.35M | -29.26M |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 31K | 64K |
Financial Cash Flow | 205.71M | 178.97M | 31K | 110.86M |
Net Cash Flow | 20.66M | -733K | -16.32M | 45.52M |
Free Cash Flow | -66.67M | -52.81M | -44.82M | -37.94M |
Adj. Free Cash Flow | -78.74M | -56.52M | -47.07M | -39.63M |
Maintenance CapEx | -377K | -27K | -583K | -122K |
Growth CapEx | n/a | n/a | -533K | -1.75M |
Owner Earnings | -66.67M | -52.81M | -44.28M | -36.19M |
Add to Watchlist
Select watchlists to add or remove SION